Cointime

Fortis Therapeutics

company

About

Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46.

  • 51 - 100

Highlights

Total Funding Amount
$58M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$18M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
51 - 100
Operating Status
Active

Fortis Therapeutics is immuno-oncology biotech focused on developing new antibody-drug conjugate therapies against CD46 for the treatment of late-stage multiple myeloma and late-stage prostate cancer and other indications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$58M
Fortis Therapeutics has raised a total of $58M in funding over 2 rounds. Their latest funding was raised on Mar 29, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 29, 2021 Series A $40M 1 — — Detail
Sep 27, 2016 Series A $18M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Fortis Therapeutics is funded by 1 investors. Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures — Series A
Cointime
เนื้อหา
บริษัท